drug
BEAM-302
Phase 2updated 5mo agoby $BEAM Beam Therapeutics Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying BEAM-302
News(2)
- Beam Therapeutics sues base editing rival, claims former scientist stole secretsBase editing biotech Beam Therapeutics is suing one of its newest rivals, alleging that the upstart company stole the secrets behind one of its lead programs and used them to craft a competing ther…fiercebiotech · 8h ago
- Beam sues 2 biotechs, alleging theft of base editing trade secretsBeam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatment at YolTech Therapeutics. Serapha Bio, which licensed that therapy, denies the charges.biopharma_dive · 1d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that